Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
(2019)
Journal Article
Baigent, C., Lasserson, D., Sullivan, F., Carrie, J., Rojas, J., Amoils, S., Bamford, J., Armitage, J., Rinkel, G., Lowe, G., Emberson, J., Innes, K., Dinsmore, L., Drever, J., Williams, C., Perry, D., McGill, C., Buchanan, D., Walker, A., Hutchison, A., …Thomas, K. (2019). Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial. Lancet, 393(10191), 2613-2623. https://doi.org/10.1016/s0140-6736%2819%2930840-2
Background Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhag... Read More about Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.